1.
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
by van Schie, K A
Annals of the rheumatic diseases, 2015, Vol.74 (1), p.311-314
2.
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
by Vande Casteele, N.
Alimentary pharmacology & therapeutics, 2012, Vol.36 (8), p.765-771
3.
Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up
by Kneepkens, E L
Annals of the rheumatic diseases, 2015, Vol.74 (10), p.1825-1829
4.
Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies
by Suurmond, J
Annals of the rheumatic diseases, 2015, Vol.74 (10), p.1915-1923
5.
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs
by Vogelzang, E H
Annals of the rheumatic diseases, 2015, Vol.74 (2), p.474-475
6.
FRI0019 Anti-IGG Subclass Specific Rheumatoid Factor Discriminates Between Restricted and Polyspecific RF Responses which are Associated with Isotype Switching and ACPA Positivity...
by Falkenburg, W
Annals of the rheumatic diseases, 2015, Vol.74 (Suppl 2), p.425-425
7.
SAT0558 Association Between Etanercept Concentrations and Disease Activity in Psoriatic Arthritis During 52 Weeks of Follow-Up
by Vogelzang, E
Annals of the rheumatic diseases, 2015, Vol.74 (Suppl 2), p.862-862
8.
Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region’ by Rinaudo-Gaujous et al
by van Schie, K A
Annals of the rheumatic diseases, 2015, Vol.74 (8), p.e41-e41
9.
THU0243 A Concentration-Effect Curve of Adalimumab in Ankylosing Spondylitis Patients; Does it Exist or Not?
by Marsman, A
Annals of the rheumatic diseases, 2015, Vol.74 (Suppl 2), p.285-285
10.
SAT0333 The Influence of Golimumab Levels on Clinical Response in Spondyloarthritis Patients at 52 Weeks of Follow-Up
by Plasencia, C
Annals of the rheumatic diseases, 2014, Vol.73 (Suppl 2), p.712-713
11.
OP0074 A Concentration-Effect Curve of Adalimumab in Patients with Psoriatic Arthritis
by Vogelzang, E
Annals of the rheumatic diseases, 2014, Vol.73 (Suppl 2), p.88-89
12.
SAT0391 A Diminished Clinical Response at 28 and 52 Weeks of Adalimumab Treatment in Patients with Psoriatic Arthritis is Associated with Anti-Drug Antibodies
by Vogelzang, E
Annals of the rheumatic diseases, 2014, Vol.73 (Suppl 2), p.735-736
13.
SAT0187 Tocilizumab Standard Dose is an Overtreatment with Regard to Systemic IL-6 Receptor Blockade in Rheumatoid Arthritis
by Kneepkens, E.L
Annals of the rheumatic diseases, 2015, Vol.74 (Suppl 2), p.723-723
14.
THU0208 Efficacy of Switching Tumor Necrosis Factor α Inhibitor to a Second Tumor Necrosis Factor α Inhibitor and the Influence of Drug Levels and Anti-Drug Antibodies in Patients...
by Ruwaard, J
Annals of the rheumatic diseases, 2015, Vol.74 (Suppl 2), p.271-271
15.
FRI0147 IgG4 antibody response upon long term treatment with adalimumab
by van Schouwenburg, P
Annals of the rheumatic diseases, 2013, Vol.71 (Suppl 3), p.360-360
16.
FRI0144 Adalimumab trough level in blood corresponding with clinical response
by Pouw, M.F
Annals of the rheumatic diseases, 2013, Vol.71 (Suppl 3), p.359-359
17.
FRI0310 Tocilizumab Levels Are Associated with Clinical Response in Patients with Rheumatoid Arthritis
by Kneepkens, E.L
Annals of the rheumatic diseases, 2014, Vol.73 (Suppl 2), p.497-498
18.
Dimerization of complement factor H-related (FHR) proteins: FHR-5 forms homodimers whereas FHR-1 and FHR-2 both homodimerize and heterodimerize with each other
by van Beek, Anna E
Immunobiology (1979), 2016, Vol.221 (10), p.1182-1183
19.
OP0177 A High Frequency of N-Glycans in the Acpa-Igg Variable Domain Modulates Reactivity to Citrullinated Antigens
by Scherer, H.U
Annals of the rheumatic diseases, 2014, Vol.73 (Suppl 2), p.129-129
20.
AB0055 Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralization
by van Schouwenburg, P
Annals of the rheumatic diseases, 2013, Vol.71 (Suppl 3), p.640-640
